STUDY OBJECTIVE: To assess the feasibility of a colorectal cancer population-based screening programme in Catalonia (Spain). DESIGN AND SETTING: A pilot colorectal cancer screening programme based on faecal occult blood (FOB) test was introduced in February 2000 in Hospitalet de Llobregat (Barcelona, Spain), a city of 239,000 inhabitants. PARTICIPANTS: All the residents from the selected area, aged 50-69 years old, were invited by mail to participate in the screening programme. Overall, 63,880 persons were invited to the first screening round and 66,534, to the second round. Colonoscopy was the first choice of procedure for the positive FOB test. RESULTS: The participation rate was 17.2% in the first screening round and 22.3% in the second round. The overall rate of positive FOBT was 3.4% in the first round and 0.8% in the second round. In the first round, the prevalence of screen-detected cancer was 2.1 per 1000 screened people, 7.2 for high-risk adenomas (HRA) and 11.3 for neoplasm (cancer and/or adenoma). The positive predictive value (PPV) was 6.2% for cancer, 21.2% for HRA and 33.3% for advanced neoplasm. In the second round, the prevalence of screen-detected cancer was 0.9 per 1000 people screened, 2.8 per 1000 for HRA and 4.2 per 1000 for neoplasm. The PPV was 10.6% for cancer, 34.1% for HRA and 50.4% for any neoplasm. CONCLUSIONS: Regardless of the moderate participation rate, population-based colorectal cancer screening would be feasible in Catalonia, with good results in terms of prevalence of screen-detected neoplasms.
STUDY OBJECTIVE: To assess the feasibility of a colorectal cancer population-based screening programme in Catalonia (Spain). DESIGN AND SETTING: A pilot colorectal cancer screening programme based on faecal occult blood (FOB) test was introduced in February 2000 in Hospitalet de Llobregat (Barcelona, Spain), a city of 239,000 inhabitants. PARTICIPANTS: All the residents from the selected area, aged 50-69 years old, were invited by mail to participate in the screening programme. Overall, 63,880 persons were invited to the first screening round and 66,534, to the second round. Colonoscopy was the first choice of procedure for the positive FOB test. RESULTS: The participation rate was 17.2% in the first screening round and 22.3% in the second round. The overall rate of positive FOBT was 3.4% in the first round and 0.8% in the second round. In the first round, the prevalence of screen-detected cancer was 2.1 per 1000 screened people, 7.2 for high-risk adenomas (HRA) and 11.3 for neoplasm (cancer and/or adenoma). The positive predictive value (PPV) was 6.2% for cancer, 21.2% for HRA and 33.3% for advanced neoplasm. In the second round, the prevalence of screen-detected cancer was 0.9 per 1000 people screened, 2.8 per 1000 for HRA and 4.2 per 1000 for neoplasm. The PPV was 10.6% for cancer, 34.1% for HRA and 50.4% for any neoplasm. CONCLUSIONS: Regardless of the moderate participation rate, population-based colorectal cancer screening would be feasible in Catalonia, with good results in terms of prevalence of screen-detected neoplasms.
Authors: M Shuhaibar; C Walsh; F Lindsay; N Lee; P Walsh; P O'Gorman; G Boran; R McLoughlin; A Qasim; N Breslin; B Ryan; H O'Connor; C O'Morain Journal: Ir J Med Sci Date: 2010-10-17 Impact factor: 1.568
Authors: Maria Ramos; Magdalena Esteva; Jesús Almeda; Elena Cabeza; Diana Puente; Rosa Saladich; Albert Boada; Maria Llagostera Journal: BMC Cancer Date: 2010-09-20 Impact factor: 4.430
Authors: Miroslav Zavoral; Stepan Suchanek; Ondrej Majek; Premysl Fric; Petra Minarikova; Marek Minarik; Bohumil Seifert; Ladislav Dusek Journal: World J Gastroenterol Date: 2014-04-14 Impact factor: 5.742
Authors: Gemma Ibáñez-Sanz; Núria Milà; Luisa C de la Peña-Negro; Montse Garcia; Carmen Vidal; Lorena Rodríguez-Alonso; Gemma Binefa; Francisco Rodríguez-Moranta; Victor Moreno Journal: J Gastroenterol Date: 2020-11-07 Impact factor: 7.527
Authors: Maria Ramos; Maria Llagostera; Magdalena Esteva; Elena Cabeza; Xavier Cantero; Manel Segarra; Maria Martín-Rabadán; Guillem Artigues; Maties Torrent; Joana Maria Taltavull; Joana Maria Vanrell; Mercè Marzo; Joan Llobera Journal: BMC Cancer Date: 2011-09-25 Impact factor: 4.430
Authors: L Sharp; L Tilson; S Whyte; A O'Ceilleachair; C Walsh; C Usher; P Tappenden; J Chilcott; A Staines; M Barry; H Comber Journal: Br J Cancer Date: 2012-02-16 Impact factor: 7.640
Authors: Linda Sharp; Lesley Tilson; Sophie Whyte; Alan O Ceilleachair; Cathal Walsh; Cara Usher; Paul Tappenden; James Chilcott; Anthony Staines; Michael Barry; Harry Comber Journal: BMC Health Serv Res Date: 2013-03-19 Impact factor: 2.655